RE:Update!
I didn't see anything in there that indicated that there were any options moving forward beyond a straight yes or no from the FDA. All the chatter about a limited indication approval for MCNA or approvals with a concurrent trial requirement must be just that, increasingly idle chatter. The good news is that they have cash for all the severances they will owe if it is a No vote. I think that was one of the update questions in the FAQ section. Good stuff!